ArticleFrontiers in oncology2025

Efficacy of lenvatinib combined with TAS-102 as second-line therapy for advanced intrahepatic cholangiocarcinoma: a case report.

Hailong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.